Pharma Journalist -

Valneva SE a specialty vaccine company, today announced that the European Commission (“EC”) has approved an agreement pursuant to which Valneva would supply up to 60 million doses of…
Read More...

Omnicell, Inc. a leading provider of medication management solutions and adherence tools for health systems and pharmacies, and Fresenius Kabi, a global health care company that…
Read More...

Arbor Biotechnologies, a biotechnology company discovering and developing the next generation of genetic medicines, announced the completion of an oversubscribed and up-sized $215…
Read More...

Karuna Therapeutics, Inc. a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological…
Read More...

Biohaven Pharmaceutical Holding Company Ltd. and Pfizer Inc. announced a strategic commercialization arrangement for rimegepant in markets outside of the United States upon approval.…
Read More...

REGENXBIO Inc. announced the closing of its Collaboration and License Agreement with AbbVie to develop and commercialize RGX-314, a potential one-time gene therapy for the treatment of…
Read More...

Eton Pharmaceuticals, Inc and Azurity Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EPRONTIA (topiramate) oral solution, 25mg/mL.…
Read More...

Profounda, Inc. ("Profounda") announced that it has received the US Food and Drug Administration's Orphan Drug Designation Approval for the use of miltefosine to treat Invasive…
Read More...

Merck known as MSD outside the United States and Canada, today announced that its pending acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN) has been cleared by the competition…
Read More...

EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced that Swissmedic has approved Bronchitol…
Read More...